K. Nagaraju, et.al., Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies., Proceedings of the National Academy of Sciences of the United States of America, 2000, 97

http://rdf.ncbi.nlm.nih.gov/pubmed/10922072

K. Nagaraju, et.al., Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies., Proceedings of the National Academy of Sciences of the United States of America, 2000, 97

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Tg(tetO-H2-K1)#Papl
  http://metadb.riken.jp/db/mgi_rdf/MGI:5547617

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• muscle weakness_Tg(CKMM-tTA)A3Rhvh/0,Tg(tetO-H2-K1)#Papl/0
  http://metadb.riken.jp/0000747B6CgTgCKMMtTAA3RhvhTgtetOH2K1PaplTgCKMMtTAA3Rhvh0TgtetOH2K1Papl0TgtetOH2K1PaplTgCKMMtTAA3Rhvh
• abnormal skeletal muscle morphology_Tg(CKMM-tTA)A3Rhvh/0,Tg(tetO-H2-K1)#Papl/0
  http://metadb.riken.jp/0000759B6CgTgCKMMtTAA3RhvhTgtetOH2K1PaplTgCKMMtTAA3Rhvh0TgtetOH2K1Papl0TgtetOH2K1PaplTgCKMMtTAA3Rhvh
• decreased body weight_Tg(CKMM-tTA)A3Rhvh/0,Tg(tetO-H2-K1)#Papl/0
  http://metadb.riken.jp/0001262B6CgTgCKMMtTAA3RhvhTgtetOH2K1PaplTgCKMMtTAA3Rhvh0TgtetOH2K1Papl0TgtetOH2K1PaplTgCKMMtTAA3Rhvh
• hypoactivity_Tg(CKMM-tTA)A3Rhvh/0,Tg(tetO-H2-K1)#Papl/0
  http://metadb.riken.jp/0001402B6CgTgCKMMtTAA3RhvhTgtetOH2K1PaplTgCKMMtTAA3Rhvh0TgtetOH2K1Papl0TgtetOH2K1PaplTgCKMMtTAA3Rhvh
• abnormal circulating enzyme level_Tg(CKMM-tTA)A3Rhvh/0,Tg(tetO-H2-K1)#Papl/0
  http://metadb.riken.jp/0001570B6CgTgCKMMtTAA3RhvhTgtetOH2K1PaplTgCKMMtTAA3Rhvh0TgtetOH2K1Papl0TgtetOH2K1PaplTgCKMMtTAA3Rhvh
• increased autoantibody level_Tg(CKMM-tTA)A3Rhvh/0,Tg(tetO-H2-K1)#Papl/0
  http://metadb.riken.jp/0003725B6CgTgCKMMtTAA3RhvhTgtetOH2K1PaplTgCKMMtTAA3Rhvh0TgtetOH2K1Papl0TgtetOH2K1PaplTgCKMMtTAA3Rhvh
他9件を見る
• abnormal spine curvature_Tg(CKMM-tTA)A3Rhvh/0,Tg(tetO-H2-K1)#Papl/0
  http://metadb.riken.jp/0004174B6CgTgCKMMtTAA3RhvhTgtetOH2K1PaplTgCKMMtTAA3Rhvh0TgtetOH2K1Papl0TgtetOH2K1PaplTgCKMMtTAA3Rhvh
• myositis_Tg(CKMM-tTA)A3Rhvh/0,Tg(tetO-H2-K1)#Papl/0
  http://metadb.riken.jp/0004510B6CgTgCKMMtTAA3RhvhTgtetOH2K1PaplTgCKMMtTAA3Rhvh0TgtetOH2K1Papl0TgtetOH2K1PaplTgCKMMtTAA3Rhvh
• increased anti-nuclear antigen antibody level_Tg(CKMM-tTA)A3Rhvh/0,Tg(tetO-H2-K1)#Papl/0
  http://metadb.riken.jp/0004794B6CgTgCKMMtTAA3RhvhTgtetOH2K1PaplTgCKMMtTAA3Rhvh0TgtetOH2K1Papl0TgtetOH2K1PaplTgCKMMtTAA3Rhvh
• cachexia_Tg(CKMM-tTA)A3Rhvh/0,Tg(tetO-H2-K1)#Papl/0
  http://metadb.riken.jp/0005150B6CgTgCKMMtTAA3RhvhTgtetOH2K1PaplTgCKMMtTAA3Rhvh0TgtetOH2K1Papl0TgtetOH2K1PaplTgCKMMtTAA3Rhvh
• abnormal cytokine level_Tg(CKMM-tTA)A3Rhvh/0,Tg(tetO-H2-K1)#Papl/0
  http://metadb.riken.jp/0008713B6CgTgCKMMtTAA3RhvhTgtetOH2K1PaplTgCKMMtTAA3Rhvh0TgtetOH2K1Papl0TgtetOH2K1PaplTgCKMMtTAA3Rhvh
• skeletal muscle fiber degeneration_Tg(CKMM-tTA)A3Rhvh/0,Tg(tetO-H2-K1)#Papl/0
  http://metadb.riken.jp/0009412B6CgTgCKMMtTAA3RhvhTgtetOH2K1PaplTgCKMMtTAA3Rhvh0TgtetOH2K1Papl0TgtetOH2K1PaplTgCKMMtTAA3Rhvh
• skeletal muscle fiber atrophy_Tg(CKMM-tTA)A3Rhvh/0,Tg(tetO-H2-K1)#Papl/0
  http://metadb.riken.jp/0009413B6CgTgCKMMtTAA3RhvhTgtetOH2K1PaplTgCKMMtTAA3Rhvh0TgtetOH2K1Papl0TgtetOH2K1PaplTgCKMMtTAA3Rhvh
• increased circulating creatine kinase level_Tg(CKMM-tTA)A3Rhvh/0,Tg(tetO-H2-K1)#Papl/0
  http://metadb.riken.jp/0010090B6CgTgCKMMtTAA3RhvhTgtetOH2K1PaplTgCKMMtTAA3Rhvh0TgtetOH2K1Papl0TgtetOH2K1PaplTgCKMMtTAA3Rhvh
• perinatal lethality, complete penetrance_Tg(CKMM-tTA)A3Rhvh/0,Tg(tetO-H2-K1)#Papl/0
  http://metadb.riken.jp/0011089B6CgTgCKMMtTAA3RhvhTgtetOH2K1PaplTgCKMMtTAA3Rhvh0TgtetOH2K1Papl0TgtetOH2K1PaplTgCKMMtTAA3Rhvh

class

http://purl.org/net/cito/citesAsAuthority

• Tg(tetO-H2-K1)#Papl
  http://metadb.riken.jp/db/mgi_rdf/MGI:5547617